Animal models in molecular biology research: Challenges, ethical imperatives, and the path to human‐relevant translation
Animal Models and Experimental Medicine · 2026
DOI: 10.1002/ame2.70236 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Animal Models and Experimental Medicine, 2026. Verfasst von Md Shajid Hossain Rafi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacology Division, Center for Life Sciences Research Bangladesh, Dhaka, Bangladesh. Hauptthemen laut MEDLINE: Translational Research, Biomedical, Molecular Biology, Disease Models, Animal, Models, Animal. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Experimental animal models have historically been pivotal in molecular biology, providing insights into gene function, disease causes, and therapeutic advancements. However, their translational relevance is increasingly scrutinized due to interspecies variations, ethical dilemmas, and restricted reproducibility. The objective of this study is to critically analyze the obstacles and ethical considerations related to animal models in molecular biology, while highlighting the promise of human‐relevant and combinatorial techniques to enhance translational outcomes. A narrative synthesis of literature published from 2013 to 2025 was performed via PubMed, Scopus, Web of Science, and Google Scholar. Research focusing on model development, translational obstacles, ethical implications, and disease‐specific applications—encompassing neurodegenerative, metabolic, oncological, hepatic, renal, and pain models—was prioritized. Animal models are indispensable but insufficient for precisely mirroring human disease. Principal challenges include species variability, infrastructural limitations, and insufficient reproducibility. Innovative approaches such as humanized models, organoids, and CRISPR/Cas9 technologies, when combined with rigorous methodologies, controlled heterogeneity, and ethical safeguards, offer a means to improve the predictability and reliability of preclinical research. Progress in molecular biology needs to include strict planning, long‐lasting infrastructure, and new ideas from interdisciplinary fields. Integrating human‐relevant and combinatorial approaches can improve the scientific integrity and ethical underpinning of biomedical research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pharmacology Division, Center for Life Sciences Research Bangladesh, Dhaka, Bangladesh.
- Department of Pharmacy, School of Life Sciences, United International University, Dhaka, Bangladesh.
- Department of Orthodontics, Bangladesh Medical University, Dhaka, Bangladesh.
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Dhaka, Dhaka, Bangladesh.
ORCID-Profile: Shahriar Mohd Shams, Syed Masudur Rahman Dewan
Zitieren
APA
Rafi, M. S. H., Sarker, M. T., Joy, F. U., Shams, S. M., Foyez, T., Mazid, M. A., & Dewan, S. M. R. (2026). Animal models in molecular biology research: Challenges, ethical imperatives, and the path to human‐relevant translation. Animal Models and Experimental Medicine. https://doi.org/10.1002/ame2.70236
Vancouver
Rafi MSH, Sarker MT, Joy FU, Shams SM, Foyez T, Mazid MA, et al. Animal models in molecular biology research: Challenges, ethical imperatives, and the path to human‐relevant translation. Animal Models and Experimental Medicine. 2026. doi:10.1002/ame2.70236
BibTeX
@article{Rafi2026,
author = {Rafi, Md Shajid Hossain and Sarker, Md Taslim and Joy, Ferdous-Ul-Haque and Shams, Shahriar Mohd and Foyez, Tahmina and Mazid, Md Abdul and Dewan, Syed Masudur Rahman},
title = {Animal models in molecular biology research: Challenges, ethical imperatives, and the path to human‐relevant translation},
journal = {Animal Models and Experimental Medicine},
year = {2026},
doi = {10.1002/ame2.70236}
}
EUVIMED